Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

NCT05476939 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

433

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma
Diffuse Midline Glioma, H3 K27M-Mutant
Diffuse Midline Glioma, H3K27-altered

Interventions

DRUG: Everolimus
DRUG: ONC201
RADIATION: Radiotherapy

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]
[object Object]
[object Object]